Bennett Lawrence Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bennett Lawrence Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$6.78M	Sell	12,495 -1,536	-11%	-$832K	2.2%	14
2015 Q3	$6.53M	Sell	14,031 -793	-5%	-$426K	2.08%	19
2015 Q2	$7.56M	Buy	14,824 +3,564	+32%	+$1.74M	1.99%	16
2015 Q1	$5.08M	Sell	11,260 -7,185	-39%	-$3.05M	1.36%	29
2014 Q4	$7.57M	Buy	+18,445	New	+$7.25M	2.04%	16

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bennett Lawrence Management's REGN Position: Q4 2015 in Review

Bennett Lawrence Management reduced its Regeneron Pharmaceuticals (REGN) stake by 11% in Q4 2015, selling an estimated $832K and leaving 12,495 shares worth $6.78M. The position accounts for 2.2% of the portfolio, ranked #14.

Bennett Lawrence Management first reported a position in REGN in Q4 2014 and has held it in 5 quarters since. The position peaked at $7.57M in Q4 2014. 576 funds tracked by Wall St. Rank hold REGN as of Q4 2015.

Bennett Lawrence Management held 12,495 shares of Regeneron Pharmaceuticals worth $6.78M as of Q4 2015.
Bennett Lawrence Management sold 1,536 Regeneron Pharmaceuticals shares in Q4 2015, an estimated $832K.
Regeneron Pharmaceuticals made up 2.2% of Bennett Lawrence Management's portfolio in Q4 2015, its #14 holding.
Bennett Lawrence Management first reported a position in Regeneron Pharmaceuticals in Q4 2014 and has held it in 5 quarters since.
Bennett Lawrence Management's Regeneron Pharmaceuticals position peaked at $7.57M in Q4 2014.
576 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2015.

Based on Bennett Lawrence Management's 13F filing for Q4 2015, filed 16 Feb 2016.